Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1099172 | 0.72 | HTR2A (0.66) | NPSR1TAAR1HTR2ADRD2CHRNB2 | |
| SCHEMBL7326109 | 0.71 | PRCP (0.50) | HTR2AHTR1ADRD2HTR2CHTR2B | |
| SCHEMBL11553145 | 0.71 | TSHR (0.37) | NPSR1TAAR1HTR2ACHRNB2CHRNA4 | |
| SCHEMBL14131459 | 0.70 | CREBBP (0.49) | NPSR1TAAR1HTR2A | |
| SCHEMBL11555703 | 0.69 | CHRNB2 (0.38) | NPSR1TAAR1HTR2ACHRNB2CHRNA4 | |
| SCHEMBL1165406 | 0.68 | CA12 (0.52) | MEN1CYP3A4CYP2D6KMT2AHTR2C | |
| SCHEMBL29370750 | 0.67 | HTR2A (0.42) | NPSR1TAAR1HTR2A | |
| Hydrochloric Acid SCHEMBL32672905 | 0.66 | CA12 (0.50) | HTR2C | |
| SCHEMBL8337767 | 0.66 | HTR2A (0.41) | NPSR1TAAR1HTR2ACHRNB2CHRNA4 | |
| SCHEMBL12635734 | 0.64 | PNMT (0.43) | HTR2AMEN1CYP3A4CYP2D6KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0042659-B1 | 5,6,6A,7-TETRAHYDRO-4H-DIBENZ(DE,G)ISOQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1984-08-29 | — | — | EP | disclosed |
| US-4425350-A | 5,6,6a,7-Tetrahydro-4H-dibenz(de,g)-isoquinoline derivatives, and their use for treating central nervous system disorders | WARNER-LAMBERT COMPANY (US) | 1984-01-10 | — | — | US | disclosed |
| US-4425350-A | 5,6,6a,7-Tetrahydro-4H-dibenz(de,g)-isoquinoline derivatives, and their use for treating central nervous system disorders | WARNER-LAMBERT COMPANY (US) | 1984-01-10 | — | — | US | disclosed |
| EP-0042659-A1 | 5,6,6a,7-Tetrahydro-4H-dibenz(de,g)isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1981-12-30 | — | — | EP | disclosed |
| EP-0042659-A1 | 5,6,6a,7-Tetrahydro-4H-dibenz(de,g)isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1981-12-30 | — | — | EP | disclosed |